Wolfgang Froestl

This inventor holds 11 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignees: Ac Immune Sa, Novartis Ag, Life Molecular Imaging Sa. Active years: 2009-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolfgang Froestl. Retrieved from https://idiyas.com/inventor/wolfgang-froestl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 6)

% Patents Active = 36.4

CIPO Patents = 2

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 22(Granted Patents)

Location History:

Basel, CH (2010)
Ecublens, CH (2009 - 2019)
(2020)

Company Filing History:

Life Molecular Imaging Sa

patents

where one patent can have more than one assignee

Years Active: 2009-2020

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10662193 - Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins (2020-05-26),

2. 10500207 - Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins (2019-12-10),

3. 9701660 - 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system (2017-07-11),

4. 9221812 - Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins (2015-12-29),

5. 8916590 - 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system (2014-12-23),

6. 8673940 - Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins (2014-03-18),

7. 8513268 - 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy (2013-08-20),

8. 8299085 - Quinazoline derivatives (2012-10-30),

9. 8012988 - N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamide (2011-09-06),

10. 7655666 - Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands (2010-02-02),

11. 7498319 - Phosphinic acid derivatives (2009-03-03),

Title: The Innovative Mind of Wolfgang Froestl

Introduction: Wolfgang Froestl is a visionary inventor based in Ecublens, Switzerland, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Wolfgang Froestl holds several patents in the areas of renewable energy, artificial intelligence, and sustainable technologies, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Wolfgang Froestl has worked with leading research institutions and technology companies to develop cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout his career, Wolfgang Froestl has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and creativity in all his projects.

Conclusion: Wolfgang Froestl's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, leaving a lasting impact on the world of technology.

Profile summary based on public USPTO records.